Annual CFO
-$28.71 M
-$20.52 M-250.71%
31 December 2023
Summary:
Forte Biosciences annual cash flow from operations is currently -$28.71 million, with the most recent change of -$20.52 million (-250.71%) on 31 December 2023. During the last 3 years, it has fallen by -$10.28 million (-55.82%). FBRX annual CFO is now -250.71% below its all-time high of -$8.19 million, reached on 31 December 2022.FBRX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$8.13 M
-$2.20 M-37.01%
30 September 2024
Summary:
Forte Biosciences quarterly cash flow from operations is currently -$8.13 million, with the most recent change of -$2.20 million (-37.01%) on 30 September 2024. Over the past year, it has increased by +$925.00 thousand (+10.21%). FBRX quarterly CFO is now -490.63% below its all-time high of -$1.38 million, reached on 30 June 2022.FBRX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$29.70 M
+$925.00 K+3.02%
30 September 2024
Summary:
Forte Biosciences TTM cash flow from operations is currently -$29.70 million, with the most recent change of +$925.00 thousand (+3.02%) on 30 September 2024. Over the past year, it has dropped by -$7.08 million (-31.26%). FBRX TTM CFO is now -936.82% below its all-time high of -$2.87 million, reached on 31 March 2020.FBRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBRX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -250.7% | +10.2% | -31.3% |
| 3 y3 years | -55.8% | -58.6% | -75.8% |
| 5 y5 years | - | - | - |
FBRX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -250.7% | at low | -490.6% | +10.2% | -262.9% | +3.0% |
| 5 y | 5 years | -250.7% | at low | -490.6% | +10.2% | -936.8% | +3.0% |
| alltime | all time | -250.7% | at low | -490.6% | +10.2% | -936.8% | +3.0% |
Forte Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.13 M(+37.0%) | -$29.70 M(-3.0%) |
| June 2024 | - | -$5.94 M(-11.0%) | -$30.63 M(+1.5%) |
| Mar 2024 | - | -$6.67 M(-25.7%) | -$30.17 M(+5.1%) |
| Dec 2023 | -$28.71 M(+250.7%) | -$8.97 M(-1.0%) | -$28.71 M(+26.8%) |
| Sept 2023 | - | -$9.06 M(+65.4%) | -$22.63 M(+45.9%) |
| June 2023 | - | -$5.47 M(+5.2%) | -$15.51 M(+35.9%) |
| Mar 2023 | - | -$5.20 M(+79.9%) | -$11.41 M(+39.5%) |
| Dec 2022 | -$8.19 M | -$2.89 M(+49.1%) | -$8.19 M(-7.8%) |
| Sept 2022 | - | -$1.94 M(+40.9%) | -$8.87 M(-26.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$1.38 M(-30.3%) | -$12.06 M(-17.5%) |
| Mar 2022 | - | -$1.98 M(-44.9%) | -$14.62 M(-12.3%) |
| Dec 2021 | -$16.68 M(-9.5%) | -$3.58 M(-30.1%) | -$16.68 M(-1.3%) |
| Sept 2021 | - | -$5.13 M(+30.2%) | -$16.90 M(-13.4%) |
| June 2021 | - | -$3.94 M(-2.3%) | -$19.51 M(-0.4%) |
| Mar 2021 | - | -$4.03 M(+6.0%) | -$19.59 M(+6.3%) |
| Dec 2020 | -$18.42 M | -$3.80 M(-50.9%) | -$18.42 M(+26.0%) |
| Sept 2020 | - | -$7.74 M(+92.7%) | -$14.62 M(+112.5%) |
| June 2020 | - | -$4.02 M(+40.2%) | -$6.88 M(+140.2%) |
| Mar 2020 | - | -$2.87 M | -$2.87 M |
FAQ
- What is Forte Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Forte Biosciences?
- What is Forte Biosciences annual CFO year-on-year change?
- What is Forte Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Forte Biosciences?
- What is Forte Biosciences quarterly CFO year-on-year change?
- What is Forte Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Forte Biosciences?
- What is Forte Biosciences TTM CFO year-on-year change?
What is Forte Biosciences annual cash flow from operations?
The current annual CFO of FBRX is -$28.71 M
What is the all time high annual CFO for Forte Biosciences?
Forte Biosciences all-time high annual cash flow from operations is -$8.19 M
What is Forte Biosciences annual CFO year-on-year change?
Over the past year, FBRX annual cash flow from operations has changed by -$20.52 M (-250.71%)
What is Forte Biosciences quarterly cash flow from operations?
The current quarterly CFO of FBRX is -$8.13 M
What is the all time high quarterly CFO for Forte Biosciences?
Forte Biosciences all-time high quarterly cash flow from operations is -$1.38 M
What is Forte Biosciences quarterly CFO year-on-year change?
Over the past year, FBRX quarterly cash flow from operations has changed by +$925.00 K (+10.21%)
What is Forte Biosciences TTM cash flow from operations?
The current TTM CFO of FBRX is -$29.70 M
What is the all time high TTM CFO for Forte Biosciences?
Forte Biosciences all-time high TTM cash flow from operations is -$2.87 M
What is Forte Biosciences TTM CFO year-on-year change?
Over the past year, FBRX TTM cash flow from operations has changed by -$7.08 M (-31.26%)